This inventor holds 1 USPTO granted patent. Top assignee: Takashi Muramatsu. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Tohru Takada: Innovator in Neutrophilic Functional Disorders
Introduction
Tohru Takada is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of inflammatory diseases. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Tohru Takada holds a patent for "Agents comprising midkine or an inhibitor thereof as active ingredient." Midkine (MK) is a retinoic acid-inducible heparin-binding growth factor that enhances neutrophilic migration. It exists in an inflammatory state at a high concentration. The midkine or its inhibitors can be utilized for treating neutrophilic functional disorders or inflammatory diseases. This patent highlights his commitment to advancing medical treatments.
Career Highlights
Tohru Takada is associated with Takashi Muramatsu, where he continues to innovate and contribute to the field. His work has garnered attention for its potential impact on healthcare and the treatment of various disorders.
Collaborations
Some of his notable coworkers include Kazuhiro Toriyama and Hisako Muramatsu. Their collaboration has likely played a role in the development of his innovative ideas and patents.
Conclusion
Tohru Takada's contributions to medical science through his patent on midkine demonstrate his dedication to improving health outcomes. His work continues to inspire advancements in the treatment of inflammatory diseases.